Question special

Could you comment on choosing the upper boundary for the 95% confidence interval? In the statistical analysis it mentioned that 1.38 was chosen because that's what was used by the FDA for registration of trials of newer anticoagulants. But if the hazard ratio for thromboembolic events was close to 1.38 would providers really feel comfortable using the results to guide their practice?